These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial. Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, Mendelsohn FO, Ameloot K, Foster M, Fischell TA, Parise H, Mahfoud F. Circulation; 2024 Jun 11; 149(24):1875-1884. PubMed ID: 38587557 [Abstract] [Full Text] [Related]
24. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Sharp ASP, Fisher NDL, Bloch MJ, Reeve-Stoffer H, Coleman L, Mullin C, Mauri L, RADIANCE-HTN Investigators. Lancet; 2018 Jun 09; 391(10137):2335-2345. PubMed ID: 29803590 [Abstract] [Full Text] [Related]
25. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency. Lauder L, Ewen S, Tzafriri AR, Edelman ER, Cremers B, Kulenthiran S, Ukena C, Linz D, Kindermann I, Tsioufis C, Scheller B, Böhm M, Mahfoud F. Cardiovasc Revasc Med; 2018 Jun 09; 19(7 Pt B):845-851. PubMed ID: 29555535 [Abstract] [Full Text] [Related]
28. Efficacy and safety of renal denervation in elderly patients with resistant hypertension. Ziegler AK, Bertog S, Kaltenbach B, Id D, Franke J, Hofmann I, Vaskelyte L, Sievert H. Catheter Cardiovasc Interv; 2015 Aug 09; 86(2):299-303. PubMed ID: 23983010 [Abstract] [Full Text] [Related]
29. Percutaneous renal sympathetic denervation: 2013 and beyond. Froeschl M, Hadziomerovic A, Ruzicka M. Can J Cardiol; 2014 Jan 09; 30(1):64-74. PubMed ID: 24365191 [Abstract] [Full Text] [Related]
32. Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 Trial. Kario K, Bhatt DL, Kandzari DE, Brar S, Flack JM, Gilbert C, Oparil S, Robbins M, Townsend RR, Bakris G. Circ J; 2016 May 25; 80(6):1404-12. PubMed ID: 27118620 [Abstract] [Full Text] [Related]
33. 12-Month Results From the Unblinded Phase of the RADIANCE-HTN SOLO Trial of Ultrasound Renal Denervation. Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp ASP, Schmieder RE, Wang Y, Saxena M, Lurz P, Sayer J, Bloch MJ, Basile J, Weber MA, Rump LC, Levy T, Sapoval M, Sanghvi K, Rader F, Fisher NDL, Gosse P, Abraham J, Claude L, Barman NC, McClure CK, Liu Y, Kirtane AJ, RADIANCE-HTN Investigators. JACC Cardiovasc Interv; 2020 Dec 28; 13(24):2922-2933. PubMed ID: 33357531 [Abstract] [Full Text] [Related]
40. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry). Kądziela J, Prejbisz A, Kostka-Jeziorny K, Dudek D, Narkiewicz K, Sadowski J, Lekston A, Gziut A, Więcek A, Buszman P, Kleinrok A, Kochman J, Czarnecka D, Januszewicz A, Witkowski A. Kardiol Pol; 2016 Dec 28; 74(9):961-8. PubMed ID: 27160171 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]